Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Clindamycin phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Clindamycin 1% aqueous lotion
1306010F0AAABAB
|
Clindamycin phosphate (Topical) | Clindamycin phosphate | Skin | 12,813 |
|
Dalacin T 1% topical lotion
1306010F0BBABAB
|
Dalacin T | Clindamycin phosphate | Skin | 10,803 |
|
Clindamycin 1% gel
1306010F0AAADAD
|
Clindamycin phosphate (Topical) | Clindamycin phosphate | Skin | 8,735 |
|
Clindamycin 2% vaginal cream
0702020E0AAAAAA
|
Clindamycin phosphate (Vaginal) | Clindamycin phosphate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7,212 |
|
Zindaclin 1% gel
1306010F0BCAAAD
|
Zindaclin | Clindamycin phosphate | Skin | 698 |
|
Dalacin T 1% topical solution
1306010F0BBAAAA
|
Dalacin T | Clindamycin phosphate | Skin | 511 |
|
Clindamycin 1% alcoholic solution
1306010F0AAAAAA
|
Clindamycin phosphate (Topical) | Clindamycin phosphate | Skin | 362 |
|
Dalacin 2% cream
0702020E0BBAAAA
|
Dalacin | Clindamycin phosphate | Obstetrics, Gynaecology and Urinary-Tract Disorders | 331 |
|
Clindamycin 300mg/2ml solution for injection ampoules
0501060E0AAAAAA
|
Clindamycin phosphate (Parenteral) | Clindamycin phosphate | Infections | 1 |
|
Clindamycin 600mg/4ml solution for injection ampoules
0501060E0AAABAB
|
Clindamycin phosphate (Parenteral) | Clindamycin phosphate | Infections | No data available |
|
Dalacin C Phosphate 300mg/2ml inj ampoules
0501060E0BBAAAA
|
Dalacin C Phosphate | Clindamycin phosphate | Infections | No data available |
|
Dalacin C Phosphate 600mg/4ml inj ampoules
0501060E0BBABAB
|
Dalacin C Phosphate | Clindamycin phosphate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.